Hannah Choe

2.1k total citations
58 papers, 315 citations indexed

About

Hannah Choe is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Hannah Choe has authored 58 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 19 papers in Oncology and 10 papers in Genetics. Recurrent topics in Hannah Choe's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Hannah Choe is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Hannah Choe collaborates with scholars based in United States, Germany and France. Hannah Choe's co-authors include Hyoungshin Park, Róbert Langer, Daniel S. Kohane, Lino Ferreira, James L.M. Ferrara, Parvathi Ranganathan, Koen van Besien, Ahmad Naim, Jingbo Yu and Jackson Tang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Blood.

In The Last Decade

Hannah Choe

46 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah Choe United States 10 139 93 90 55 44 58 315
Francesco Zinno Italy 11 124 0.9× 85 0.9× 47 0.5× 41 0.7× 12 0.3× 30 247
Shaun R. Opie United States 6 148 1.1× 51 0.5× 63 0.7× 32 0.6× 28 0.6× 9 312
Susan S. Kelly United States 8 122 0.9× 57 0.6× 61 0.7× 45 0.8× 6 0.1× 16 279
Maria Vittoria Gazzola Italy 9 175 1.3× 55 0.6× 63 0.7× 33 0.6× 9 0.2× 13 332
T. Sadeghi United States 5 237 1.7× 65 0.7× 136 1.5× 65 1.2× 7 0.2× 11 358
Maria Saduś‐Wojciechowska Poland 10 182 1.3× 48 0.5× 42 0.5× 58 1.1× 12 0.3× 25 277
Rosa Goterris Spain 7 113 0.8× 76 0.8× 26 0.3× 57 1.0× 14 0.3× 15 235
Maria Dassi Italy 11 271 1.9× 105 1.1× 28 0.3× 91 1.7× 8 0.2× 24 389
Chihiro Yamamoto Japan 10 111 0.8× 56 0.6× 70 0.8× 68 1.2× 3 0.1× 45 295
Esther Fasse Netherlands 13 38 0.3× 335 3.6× 45 0.5× 59 1.1× 44 1.0× 16 446

Countries citing papers authored by Hannah Choe

Since Specialization
Citations

This map shows the geographic impact of Hannah Choe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Choe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Choe more than expected).

Fields of papers citing papers by Hannah Choe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Choe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Choe. The network helps show where Hannah Choe may publish in the future.

Co-authorship network of co-authors of Hannah Choe

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Choe. A scholar is included among the top collaborators of Hannah Choe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Choe. Hannah Choe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wall, Sarah, Sam Penza, Kevin K.W. Ho, et al.. (2025). Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd. Transplantation and Cellular Therapy. 31(2). S82–S83.
2.
Mehta, Rohtesh S., Hannah Choe, Jennifer N. Saultz, et al.. (2025). Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Hematology. 100(6). 987–997.
3.
DeFilipp, Zachariah, Hannah Choe, Yvonne A. Efebera, et al.. (2025). RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT. Blood. 146(17). 2037–2046. 1 indexed citations
4.
Shune, Leyla, Anthony S. Stein, Damiano Rondelli, et al.. (2025). Safety analysis of axatilimab in patients with chronic graft-versus-host disease in an expanded access program. Blood. 146(Supplement 1). 6008–6008.
5.
Choe, Hannah, Sally Arai, Panagiotis Tsirigotis, et al.. (2025). Kinetics and Management of Hepatic Laboratory Elevations Associated with Axatilimab in the Agave-201 Study. Transplantation and Cellular Therapy. 31(2). S291–S292.
6.
Kaur, M., Ashley Gray, Michael J. Diaz, et al.. (2024). Dermatologic manifestations of acute graft-versus-host disease after solid organ transplantation: A systematic review. 1. 125–130. 1 indexed citations
7.
Choe, Hannah, Amandeep Salhotra, Nosha Farhadfar, et al.. (2024). Dynamics of Overall and Organ-Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study. Blood. 144(Supplement 1). 98–98.
8.
Silberman, Pedro C., Yazeed Sawalha, Beth Christian, et al.. (2024). Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 42(16_suppl). 7033–7033. 2 indexed citations
9.
Jiang, Justin, Audrey M. Sigmund, Qiuhong Zhao, et al.. (2024). Impact of chronic graft- versus -host disease on non-relapse mortality and survival. Leukemia & lymphoma. 65(11). 1698–1705. 1 indexed citations
10.
Abedi, Mehrdad, Samer A. Srour, Amandeep Salhotra, et al.. (2024). Preliminary Safety and Efficacy of Myeloablative Orca-Q with No GvHD Prophylaxis for Treatment of Advanced Hematologic Malignancies. Blood. 144(Supplement 1). 382–382. 3 indexed citations
11.
Wall, Sarah, Sumithira Vasu, Sam Penza, et al.. (2024). Real-World Clinical Outcomes of Severe, Treatment-Refractory Chronic Gvhd Patients Treated with Axatilimab Combination Therapies. Blood. 144(Supplement 1). 7362–7362. 1 indexed citations
12.
Gray, Ashley, Catherine Chung, Lucia Seminario‐Vidal, et al.. (2023). Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil. JAAD Case Reports. 36. 82–88. 2 indexed citations
13.
14.
Holtan, Shernan G., Jingbo Yu, Hannah Choe, et al.. (2022). Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review. Bone Marrow Transplantation. 57(10). 1581–1585. 23 indexed citations
15.
Holtan, Shernan G., Jingbo Yu, Dilan Paranagama, et al.. (2022). Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study. Bone Marrow Transplantation. 57(9). 1399–1404. 9 indexed citations
16.
Zitzer, Nina C., Yandi Gao, Hannah Choe, et al.. (2020). PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease. JCI Insight. 5(8). 27 indexed citations
17.
Zhao, Qiuhong, Patrick Elder, Jonathan E. Brammer, et al.. (2020). Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Leukemia & lymphoma. 62(4). 944–951. 5 indexed citations
18.
Choe, Hannah, Usama Gergis, Tsiporah B. Shore, et al.. (2017). Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD. Blood. 130. 5500–5500. 1 indexed citations
19.
Choe, Hannah, Andrea Sboner, Himisha Beltran, David M. Nanus, & Scott T. Tagawa. (2016). PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma. Thrombosis Research. 140. S192–S192. 4 indexed citations
20.
Choe, Hannah, Mohamed Elfil, & Maria T. DeSancho. (2015). Inherited antithrombin deficiency and anabolic steroids. Blood Coagulation & Fibrinolysis. 27(6). 717–719. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Zinno Breakdown of academic impact, for papers by Shaun R. Opie Breakdown of academic impact, for papers by Susan S. Kelly Breakdown of academic impact, for papers by Maria Vittoria Gazzola Breakdown of academic impact, for papers by T. Sadeghi Breakdown of academic impact, for papers by Maria Saduś‐Wojciechowska Breakdown of academic impact, for papers by Rosa Goterris Breakdown of academic impact, for papers by Maria Dassi Breakdown of academic impact, for papers by Chihiro Yamamoto Breakdown of academic impact, for papers by Esther Fasse
Rankless by CCL
2026